{
  "subset": "contraindication",
  "disease": "Hereditary haemorrhagic telangiectasia",
  "relation": "contraindication",
  "gold_drugs": [
    "pomalidomide oral product",
    "protopic® 0.1% ointment",
    "timolol gel"
  ],
  "seeds_initial": [
    "Angiotensin-converting enzyme inhibitors",
    "NSAIDs",
    "Aspirin",
    "Clopidogrel",
    "Warfarin",
    "Heparin",
    "Thrombolytics",
    "Antiplatelet agents",
    "Selective serotonin reuptake inhibitors",
    "Tramadol",
    "Corticosteroids",
    "Cisplatin",
    "Vasopressors",
    "Bromocriptine",
    "Valproate",
    "Anticoagulants",
    "Non-steroidal anti-inflammatory drugs",
    "Beta-blockers",
    "Dabigatran",
    "Rivaroxaban",
    "Apixaban",
    "Tiagabine",
    "Fluoxetine",
    "Sertraline",
    "Venlafaxine",
    "Diclofenac",
    "Ibuprofen",
    "Meloxicam",
    "Indomethacin",
    "Naproxen",
    "Piroxicam",
    "Sildenafil",
    "Fibrates",
    "Statins",
    "Thiazolidinediones",
    "Sulfonylureas",
    "Atypical antipsychotics",
    "Chlorpromazine",
    "Quetiapine",
    "Risperidone",
    "Lithium",
    "Acetaminophen",
    "Mefenamic acid",
    "Ketorolac",
    "Azathioprine",
    "Mercaptopurine",
    "Tacrolimus",
    "Mycophenolate mofetil",
    "Interferons",
    "Systemic corticosteroids",
    "Anabolic steroids",
    "Methotrexate",
    "Cyclophosphamide",
    "Tricyclic antidepressants",
    "Ephedrine",
    "Pseudoephedrine",
    "Cocaine",
    "Alcohol",
    "St. John’s Wort"
  ],
  "seed_history": [
    [
      "Angiotensin-converting enzyme inhibitors",
      "NSAIDs",
      "Aspirin",
      "Clopidogrel",
      "Warfarin",
      "Heparin",
      "Thrombolytics",
      "Antiplatelet agents",
      "Selective serotonin reuptake inhibitors",
      "Tramadol",
      "Corticosteroids",
      "Cisplatin",
      "Vasopressors",
      "Bromocriptine",
      "Valproate",
      "Anticoagulants",
      "Non-steroidal anti-inflammatory drugs",
      "Beta-blockers",
      "Dabigatran",
      "Rivaroxaban",
      "Apixaban",
      "Tiagabine",
      "Fluoxetine",
      "Sertraline",
      "Venlafaxine",
      "Diclofenac",
      "Ibuprofen",
      "Meloxicam",
      "Indomethacin",
      "Naproxen",
      "Piroxicam",
      "Sildenafil",
      "Fibrates",
      "Statins",
      "Thiazolidinediones",
      "Sulfonylureas",
      "Atypical antipsychotics",
      "Chlorpromazine",
      "Quetiapine",
      "Risperidone",
      "Lithium",
      "Acetaminophen",
      "Mefenamic acid",
      "Ketorolac",
      "Azathioprine",
      "Mercaptopurine",
      "Tacrolimus",
      "Mycophenolate mofetil",
      "Interferons",
      "Systemic corticosteroids",
      "Anabolic steroids",
      "Methotrexate",
      "Cyclophosphamide",
      "Tricyclic antidepressants",
      "Ephedrine",
      "Pseudoephedrine",
      "Cocaine",
      "Alcohol",
      "St. John’s Wort"
    ],
    [
      "Bevacizumab",
      "Thalidomide",
      "Aspirin",
      "Warfarin",
      "Clopidogrel",
      "Dabigatran",
      "Apixaban",
      "Rivaroxaban",
      "Labetalol",
      "Hydrochlorothiazide",
      "Methotrexate",
      "Cyclosporine",
      "Sirolimus",
      "Everolimus",
      "Sildenafil",
      "Tadalafil",
      "Mifepristone",
      "Infliximab",
      "Adalimumab",
      "Ustekinumab",
      "Rituximab",
      "Trastuzumab",
      "Tamoxifen",
      "Carboplatin",
      "Cisplatin",
      "Oxaliplatin",
      "Dexamethasone",
      "Fenofibrate",
      "Simvastatin",
      "Atorvastatin",
      "Rosuvastatin",
      "Ibuprofen",
      "Naproxen",
      "Ketorolac",
      "Celecoxib",
      "Meloxicam",
      "Diclofenac",
      "Amitriptyline",
      "Gabapentin",
      "Pregabalin",
      "Tramadol",
      "Codeine",
      "Morphine",
      "Oxycodone",
      "Hydrocodone",
      "Fentanyl",
      "Naloxone",
      "Lidocaine",
      "Bupivacaine",
      "Furosemide",
      "Spironolactone",
      "Metoprolol",
      "Propranolol",
      "Carvedilol",
      "Clonidine",
      "Quinapril",
      "Lisinopril"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_warfarin",
          "name": "Warfarin"
        },
        "score": 0.7,
        "graph_snapshot_ref": "GE_H4_round5",
        "key_assumptions": [
          "药物影响血液凝固",
          "出血风险显著"
        ],
        "caveats": [
          "长期疗效及安全性需更多实证支持"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_clopidogrel",
          "name": "Clopidogrel"
        },
        "score": 0.69,
        "graph_snapshot_ref": "GE_H5_round5",
        "key_assumptions": [
          "同类药物影响出血风险",
          "对HHT患者存在危险性"
        ],
        "caveats": [
          "可能存在长期使用的安全性担忧"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_bevacizumab",
          "name": "Bevacizumab"
        },
        "score": 0.68,
        "graph_snapshot_ref": "GE_H1_round5",
        "key_assumptions": [
          "已知因药物作用引发的风险",
          "关系明确"
        ],
        "caveats": [
          "出血风险需要进一步探讨"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "药物→出血风险→不良表型",
          "reason": "影响出血的机制链条已被验证，且有多条支持的边连接"
        }
      ],
      "remaining_gaps": [
        "出血风险与长期疗效的具体数据缺乏",
        "部分候选药物对其他影响需要进一步验证"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C",
            "D"
          ],
          "impact_summary": "为创建兼容的禁忌症数据提供支持"
        },
        {
          "round": 2,
          "seeds": [
            "E",
            "F"
          ],
          "impact_summary": "强化了与风险相关的证据链"
        }
      ],
      "lessons": [
        "对潜在出血的监测需引入随访研究",
        "考虑患者基线特征对药物安全性的影响"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "明确列出每种药物的出血风险及潜在影响"
      },
      {
        "role": "Skeptic",
        "patch": "提供针对潜在出血风险的对照性证据"
      },
      {
        "role": "Explorer",
        "patch": "探索与给药路径相关的新候选药物"
      }
    ],
    "heuristics": [
      {
        "when": "考量HHT病人用药",
        "then": "优先选择出血风险明确的药物"
      },
      {
        "when": "出血风险季节性加重",
        "then": "必需重新评估给药方案"
      }
    ]
  }
}